(Press-News.org) ROCKVILLE, Md. — Oct. 8, 2025 — The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of new best practice recommendations for improving how complex molecular profiling information is presented to oncologists and other healthcare providers. The manuscript, titled “Developing Consensus for a More Provider-Friendly Next-Generation Sequencing Molecular Biomarker Report: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists,” was published online ahead of print, and the full text is freely available in The Journal of Molecular Diagnostics. The biomarker report template is available on AMP’s website.
While next-generation sequencing testing for solid tumors is increasingly available, its use has been limited due to widespread shortages of qualified clinical laboratory professionals and the complexities involved in data interpretation. Most clinical laboratories produce their own report formats, which can vary significantly in terms of length and organization of results and other content. To address these issues, AMP’s Clinical Practice Committee convened a multidisciplinary panel of experts to create a simplified and consensus-driven biomarker report template that providers could review and utilize more effectively for patient care. The AMP Provider-Friendly Biomarker Report Working Group included representatives from AMP, the American Society of Clinical Oncology and the College of American Pathologists.
Alanna J. Church, M.D., is the chair of AMP’s Clinical Practice Committee and director of innovation in pediatric cancer genomics at Boston Children’s Hospital. “Oncologists who receive our molecular biomarker reports typically need to assess the clinical impact of specific somatic mutations, determine whether any available therapies target those mutations and evaluate the strength of supporting evidence in order to provide the best care for their patient,” said Church. “This new highly anticipated biomarker report template offers recommendations to help laboratories implement the presentation of complex molecular profiling data in a clear, yet guideline-concordant format specifically designed for oncologists and other healthcare providers.”
The working group’s proposed report template was informed by the team’s clinical expertise and a review of 17 NGS biomarker reports for solid tumors from public, private and academic laboratories. The template also incorporates extensive community feedback from a public comment period. The panel of experts assessed specific components, including overall report length, presence of a summary section and biomarker results table, use of color and formatting, therapeutic guidance, references to clinical practice guidelines, inclusion of clinical trial options, background information on biomarkers, assay and coverage details and clear explanations of variants of uncertain significance.
AMP President Jane S. Gibson, Ph.D., is the lead author of the paper. She is also a Pegasus-awarded professor of pathology, chair of the Department of Clinical Sciences and director of molecular diagnostics at the University of Central Florida College of Medicine. “This joint consensus recommendation is intended to support broader use of NGS testing and to help optimize patient care,” Gibson said. “AMP is committed to revisiting and refining the report template as advances in science, technology and clinical practice continue to evolve.”
The biomarker report project was supported by an unrestricted continuing medical education grant from AstraZeneca and Daiichi Sankyo.
To read the full manuscript, please visit https://doi.org/10.1016/j.jmoldx.2025.08.011.
Live Webinar
AMP is hosting a webinar to provide additional details on the key aspects of the proposed provider-friendly report template.
Developing Consensus for a More Provider-Friendly NGS Molecular Biomarker Report
Presenter: Jane S. Gibson, Ph.D., University of Central Florida College of Medicine
Moderator: Anthony N. Snow, M.D., University of Iowa Hospitals and Clinics
Date / Time: Thursday, Dec. 18, at 2:30 p.m. ET
To register in advance: Click here.
About AMP
Association for Molecular Pathology was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP’s more than 3,100 members practice various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions and oncology. Our members are pathologists, clinical laboratory directors, basic and translational scientists, technologists and trainees who practice in a variety of settings, including academic and community medical centers, government and industry. Through the efforts of its Board of Directors, Committees, Working Groups and Members, AMP is the primary resource for expertise, education and collaboration in one of the fastest-growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high-quality, appropriate testing. For more information, visit www.amp.org.
END
We mostly take it for granted that the position shown by our GPS is correct.
But if we are in a new city and use the map app on our phone to find our way back to the hotel, it can often look like we are jumping around from one point to another – even though we are actually walking perfectly normally on the same pavement the whole time.
“Cities are brutal for satellite navigation,” explained Ardeshir Mohamadi.
He is a doctoral fellow at the Norwegian University of Science and Technology (NTNU) ...
A Northwestern University-led team of astronomers has captured the most detailed glimpse yet of a doomed star before it exploded.
Using NASA’s James Webb Space Telescope (JWST), the international team identified a supernova’s source star, or progenitor, at mid-infrared wavelengths for the first time. These observations — combined with archival images from the Hubble Space Telescope — revealed the explosion came from a massive red supergiant star, cloaked in an unexpected shroud of dust.
The discovery may help solve the decades-old mystery of why massive red supergiants rarely explode. Afterall, theoretical models predict red ...
Embargoed until 7 a.m. CT/8 a.m. ET, Wednesday, Oct. 8, 2025
DALLAS, Oct. 8, 2025 — Amit Khera, M.D., FAHA, director of preventive cardiology and clinical chief of cardiology at the University of Texas (UT) Southwestern Medical Center, will receive the 2025 Chairman’s Award at the American Heart Association’s Scientific Sessions. The meeting, to be held Nov. 7-10, 2025, in New Orleans, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. Dr. Khera will receive the ...
Root-knot nematodes (RKNs) are worm-like parasites of the genus Meloidogyne that are found in many parts of the world. They attack the roots of plants, causing them to wilt and eventually die. It is estimated that crops worth nearly USD 173 billion are lost every year due to RKN infestations. While chemical pesticides are effective in controlling RKNs, they also kill other microorganisms that are beneficial to plants, thereby reducing soil fertility. New, less toxic control methods are needed to prevent the loss of crops and soil fertility to RKNs.
Cellular slime mold ...
Keloids are raised, overgrown scars that can develop after skin injuries or surgery, often extending beyond the original wound boundaries. For many people, keloids are more than just a cosmetic concern; they often cause distressing symptoms such as chronic pain, itching, and restricted movement. While various treatment options exist, such as surgical removal, steroid injections, and radiation, keloids are notoriously difficult to manage, with recurrence rates reaching as high as 30%.
Even after decades of study, it is still unclear why keloids grow uncontrollably, unlike hypertrophic scars. The current understanding is that an overproduction of extracellular ...
(Boston)—The prevalence of Alzheimer disease (AD) is approximately two times higher in African Americans (AA) compared to White/European-ancestry (EA) individuals living in the U.S. Some of this is due to social determinants of health such as disparities in health care access and quality of education, biases in testing and higher rates of AD risk factors such as cardiovascular disease and diabetes in those who identify as African American.
Although many studies have examined differences in gene expression (measure of the amount of protein encoded by a gene) in brain tissue from AD cases and controls in EA or mixed ancestry ...
In the form of a ‘nasal spray’, tiny gold particles act as carriers, delivering a treatment directly to the brain: developed by scientists at the Università Cattolica Rome campus/Fondazione Policlinico Universitario A. Gemelli IRCCS, a new nanotechnological device for the treatment and prevention of neuropsychiatric and neurodegenerative diseases. These are lithium-loaded gold nanoparticles (lithium is already in clinical use for manic-depressive syndrome, but in oral formulation, not free from side effects) to combat neuropsychiatric diseases such as bipolar disorder, neurodegenerative diseases such as Alzheimer's disease, and brain infections such as those caused ...
Many Americans choose food based on cost and nutrition, but personal values, such as animal welfare and environmental concerns, also shape what ends up on our plates.
Now, researchers at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University and the University of Nottingham Rights Lab and School of Geography have measured the risk of forced labor behind ingredients in recommended U.S. diets. By showing when healthy eating may come at the expense of exploited workers, the findings ...
A new study co-led by the University of Oxford and Google Cloud has shown how general-purpose AI can accurately classify real changes in the night sky — such as an exploding star, a black hole tearing apart a passing star, a fast-moving asteroid, or a brief stellar flare from a compact star system — and explain its reasoning, without the need for complex training.
Published today (8 October) in Nature Astronomy, the study by researchers from the University of Oxford, Google Cloud, and Radboud University demonstrates that a general-purpose ...
Baltimore, MD — October 8, 2025 — Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa.
Results were published today in the journal Nature Medicine.
The investigational Trivalent Salmonella Conjugate Vaccine (TSCV) includes sugar molecules taken from the outer coating of the Salmonella typhi bacteria that cause typhoid and ...
